Skip to main content
Download PDF
  • Retraction Note
  • Open access
  • Published:

Retraction Note: ZKSCAN3 drives tumor metastasis via integrin β4/FAK/AKT mediated epithelial-mesenchymal transition in hepatocellular carcinoma

Cancer Cell International volume 24, Article number: 375 (2024) Cite this article

The Original Article was published on 05 June 2020

Retraction Note to: Cancer Cell International (2020) 20:216

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12935-020-01307-7

The Editor in Chief has retracted this article because after publication it was noted that Fig. 6C has been previously published in another publication [1] and due to an overlap of the image in Fig. 2D with another publication [2]. The Editor in Chief has therefore lost confidence in the integrity of the results of this article.

Nan Yang has agreed to this retraction on behalf of all authors.

References

  1. Xu Q, Liu X, Liu Z, et al. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Mol Cancer. 2017;16:103. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12943-017-0675-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Yao B, Li Y, Wang L, Chen T, Niu Y, Liu Q, Liu Z. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9. Artif Cells Nanomed Biotechnol. 2019;47(1);3885–3895. https://doiorg.publicaciones.saludcastillayleon.es/10.1080/21691401.2019.1670190.

Download references

Author information

Authors and Affiliations

  1. Department of Nurse, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, Shaanxi, China

    Jieqiong Li

  2. Department of Surgical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, Shaanxi, China

    Nan Hao

  3. Department of Intensive Care Unit, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, Shaanxi, China

    Juan Han

  4. Department of Nurse, Shaanxi University of Chinese Medicine, Xianyang, 712046, Shaanxi, China

    Mi Zhang

  5. School of Nurse, Xi’an Jiaotong University, Xi’an, 710061, Shaanxi, China

    Xiaomei Li

  6. Department of Infectious Diseases, The First Affiliated Hospital of Xi’an Jiaotong University, No. 277 Yanta West Road, Xi’an, 710061, Shaanxi, China

    Nan Yang

Authors
  1. Jieqiong Li
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Nan Hao
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Juan Han
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Mi Zhang
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Xiaomei Li
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Nan Yang
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence to Xiaomei Li or Nan Yang.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12935-020-01307-7.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Hao, N., Han, J. et al. Retraction Note: ZKSCAN3 drives tumor metastasis via integrin β4/FAK/AKT mediated epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Cell Int 24, 375 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12935-024-03566-0

Download citation

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12935-024-03566-0

Cancer Cell International

ISSN: 1475-2867

Contact us